This week, an op-ed was published in The Conversation, discussing a lack of transparency regarding the materials used to manufacture tampons and other period products. Studies have shown the presence of endocrine disruptors in period products, including “phthalates, volatile organic compounds, parabens, environmental phenols, fragrance chemicals, dioxins, and dioxin-like compounds,” according to a 2024 study.

The study concludes, “Research gaps were identified, including the lack of studies on newer products such as menstrual underwear and cups/discs.” Poppy Taylor, PhD candidate and women’s health researcher for the University of Bristol’s Digital Footprints Lab wrote in her The Conversation piece that the UK regulates menstrual pads under the same regulation as candles. Despite the products being used internally, manufacturers don’t have to disclose the materials used during production.

The UN Environmental Programme released a report in 2021 regarding single-use menstrual products. The report states these products “can contain up to 90% plastic and are often individually wrapped.” The report estimates that 49 billion single-use menstrual products are used in the European Union each year and 19 billion in the United States.

A 2023 study published in Reproductive Toxicology found links between four common endocrine disruptors found in period products and endometriosis.

The World Health Organization (WHO) describes endometriosis as “a disease in which tissue similar to the lining of the uterus grows outside the uterus. It can cause severe pain in the pelvis and make it harder to get pregnant.” The WHO adds, “The cause of endometriosis is unknown. There is no known way to prevent endometriosis. There is no cure, but its symptoms can be treated with medicines or, in some cases, surgery.”

The study evaluated polychlorinated biphenyls (PCBs), dioxins (TCDD), bisphenol A (BPA) and its analogs, and phthalates. The researchers concluded, “The epidemiological and experimental data discussed in this review indicate that these four EDCs activate multiple intracellular signaling pathways associated with proinflammation, estrogen, progesterone, prostaglandins, cell survival, apoptosis, migration, invasion, and growth of endometriosis. The available information strongly indicates that environmental exposure to EDCs such as PCBs, dioxins, BPA, and phthalates individually or collectively contribute to the pathophysiology of endometriosis.”

A 2024 study estimates that 6.4% of women in America had endometriosis between 2011-2019. A 2021 study from the Indian Journal of Medical Research estimated the prevalence of endometriosis in developing countries to be 18%.

A 2024 study in Environment International tested tampons for 16 metals: arsenic, barium, calcium, cadmium, cobalt, chromium, copper, iron, manganese, mercury, nickel, lead, selenium, strontium, vanadium, and zinc. The researchers concluded, “We found measurable concentrations of all 16 metals assessed. We detected concentrations of several toxic metals, including elevated mean concentrations of lead (geometric mean [GM] = 120 ng/g), cadmium (GM = 6.74 ng/g), and arsenic (GM = 2.56 ng/g).”

American Scientist reported about the harmful effects of endocrine disruptors on menstruation. Author Kate Clancy wrote, “In the case of lead, much of it is stored in bone. Because bone turnover increases in pregnancy and because lead can pass through the placenta, fetuses can experience significant lead exposure if their mothers were previously exposed.”

Clancy further explains that researchers have only recently begun studying and measuring the “epigenetic effects of phthalates across the generations.” She adds, “Epigenetic effects have the potential to occur not only in, say, a prenatally exposed generation, but also in the unexposed offspring of the following generation: the grandchildren of the originally exposed parents.”

In September, the FDA began an investigation after studies found metals in period products. That report was released in December, 2024. The purpose was to evaluate the existing literature regarding contaminants in period products. In regards to health outcomes, the FDA concluded “The body of evidence that we identified demonstrated that it is unlikely that vaginal tampon use is associated with harmful health outcomes.”

The report adds that reported vaginal ulcerations “appear to be related to the daily tampon use, as they were resolved when tampon use was stopped…However, tampons are not designed for daily use outside the menstrual cycle. The patients in this study had other health conditions that likely led them to use tampons daily.”

The FDA report states that Shearston’s 2024 study that found lead, cadmium, and arsenic in “microwave-acid digested tampons” came back with numbers that were not statistically significant for blood metals. The report concludes, “Additional studies are needed to illuminate the relationships between vaginal tampon use and exposure to contaminants.”

In the United States, period products are regulated as medical devices and are approved based on the FDA’s analysis of manufacturer-provided data. It does not mandate testing for specific contaminants. The FDA’s 2005 guidance document only mentions dioxins and pesticide residues as contaminants of interest. It is recommended, not mandated, that manufacturers test for these contaminants.

Former New York Governor Andrew Cuomo signed a law in 2019 requiring menstrual products to contain an ingredient list. This law has been criticized for being too short and leaving open-ended questions. For example, the law only requires manufacturers to disclose ingredients that were intentionally added to the product. 

Disposable menstrual products have also been criticized for their environmental impact. The International Journal of Gynaecology & Obstetrics published an editorial in 2022. The authors wrote, “While in a landfill, disposable pads are estimated to take 500 to 800 years to break down, and materials such as plastic never truly biodegrade. This is of major concern given that each menstruator will use and dispose of between 5,000 and 15,000 pads and tampons in their lifetime.”

Poppy Taylor reported that in a survey, only 2.4% of 18-24-year-olds “were taught about sustainable alternatives to single-use tampons and menstrual pads.”

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

A new fluoride study has been criticized for being a tool of the industry to promote continued water fluoridation following the banning of the practice in Utah and Florida. The authors conducted a simulation model and cost-effectiveness analysis with data from 8484 children with a mean age of 9.6 years. The authors concluded eliminating fluorideContinue reading New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

More news about Health & Nutrition

Vaccines

HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

HHS has terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine. HHS spokesman Andrew Nixon said the decision is about “safety, integrity, and trust.” He added that “mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimateContinue reading HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

More news about Vaccines

Science & Tech

Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

A viral video released from an undisclosed Chinese factory shows a humanoid robot malfunctioning and attacking the factory workers. The Unitree H1, a product of the Chinese company Unitree Robotics, can be seen flailing its arms as workers move away to protect themselves. The robot was hung on a crane, and the workers were notContinue reading Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

More news about Science & Tech

Environment

CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

Newsnation reported this week that the CDC advised local health care providers in East Palestine, OH, not to test local residents for chemical illnesses after the town was exposed to a toxic plume from a “controlled burn” after the Norfolk Southern train derailment in 2023. A lawsuit has been filed against Norfolk Southern and moreContinue reading CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

More news about Environment

Policy

HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

HHS Secretary Robert F. Kennedy Jr. wrote a letter addressed to healthcare providers saying he expects them to update their “treatment protocols and training to ensure that care for children with gender dysphoria is evidence-based.” The letter was also addressed to healthcare risk managers and state medical boards. The letter refers to the report publishedContinue reading HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

More news about Policy